HighTower Advisors
CLVS

HighTower Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

HighTower Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8,375
Closed -$207K – 2552
2019
Q1 		$207K Buy
+8,375
New +$210K ﹤0.01% 1941
2018
Q4 		– Sell
-8,845
Closed -$263K – 2411
2018
Q3 		$263K Sell
8,845
-2,025
-19% -$78.4K ﹤0.01% 1796
2018
Q2 		$495K Buy
10,870
+6,673
+159% +$325K ﹤0.01% 1455
2018
Q1 		$222K Buy
+4,197
New +$245K ﹤0.01% 1827
2017
Q4 		– Sell
-2,391
Closed -$195K – 2412
2017
Q3 		$195K Sell
2,391
-1,538
-39% -$122K ﹤0.01% 1921
2017
Q2 		$367K Buy
+3,929
New +$240K ﹤0.01% 1519
2016
Q4 		– Sell
-16,625
Closed -$598K – 2069
2016
Q3 		$598K Buy
+16,625
New +$357K 0.01% 1147
2016
Q2 		– Sell
-10,425
Closed -$199K – 2078
2016
Q1 		$199K Buy
10,425
+2,125
+26% +$45K ﹤0.01% 1811
2015
Q4 		$292K Buy
8,300
+3,793
+84% +$245K ﹤0.01% 1584
2015
Q3 		$415K Buy
4,507
+1,100
+32% +$95.2K 0.01% 1293
2015
Q2 		$300K Buy
+3,407
New +$292K ﹤0.01% 1195

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return